The Patent Finder
IN

Insulet Corporation

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

431 patents currently held

4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
16 more records may belong here and await a decision; they are not counted.

The next term ends in Jan 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
101
Ending by 2030
Jan 2027
Next term end
232
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Fluid Component Analysis System and Method for Glucose Monitoring and Control US 7,972,296
Cited by 511 later US patents, top 1% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Ends Oct 2028 · High confidence
Also notable
Disposable, Wearable Insulin Dispensing Device, a Combination of Such a Device and a Programming Controller and a Method of Controlling the Operation of Such a Device US 7,785,288
Cited by 466 later US patents, top 1% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Oct 2027 · High confidence
Also notable
Infusion Pump System and Methods US 11,260,169
Cited by 51 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2034.
Ends Nov 2034 · High confidence

Formerly held, still cited

Notable
Cited by 104 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Ends Dec 2033 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 30, 2026
    The maintenance fee for Semi-Rigid and Flexible Elements for Wearable Drug Delivery Device Reservoir (US 11,660,389) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
  • 6 fees due Dec 4 to 27, 2026 · next Dec 4
  • 7 fees due Jan 2 to 30, 2027 · next Jan 2
  • 6 fees due Feb 13 to 28, 2027 · next Feb 13
  • 7 fees due Mar 5 to 26, 2027 · next Mar 5
  • 9 fees due Apr 8 to 30, 2027 · next Apr 8
  • 1 fee due May 21, 2027
    The maintenance fee for Needle Mechanism Module for Drug Delivery Device (US 11,819,675) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 3 fees due Jun 5 to 10, 2027 · next Jun 5
  • 4 fees due Jul 2 to 30, 2027 · next Jul 2
  • 6 fees due Aug 16 to 27, 2027 · next Aug 16
  • 9 fees due Sep 3 to 30, 2027 · next Sep 3
  • 9 fees due Oct 5 to 30, 2027 · next Oct 5
  • 1 fee due Nov 19, 2027
    The maintenance fee for Basal Insulin Management (US 10,658,084) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 28 of the patents on this record were granted since Aug 23, 2026
  • 18 terms have ended since Aug 23, 2026

What they patent

The largest of its 232 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,922,708Operating an Infusion Pump System
In force
 · High confidence
In forceHigh confidence
US 7,794,428Operating an Infusion Pump System
In force
 · Medium confidence
In forceMedium confidence
US 9,114,209Method and System for Manual and Autonomous Control of an Infusion Pump
In force
 · High confidence
In forceHigh confidence
US 8,551,046Dispensing Fluid from an Infusion Pump System
In force
 · High confidence
In forceHigh confidence
US 8,622,966Operating an Infusion Pump System
In force
 · High confidence
In forceHigh confidence
US 9,872,957Operating an Infusion Pump System
In force
 · High confidence
In forceHigh confidence
US 10,307,536Operating an Infusion Pump System
In force
 · High confidence
In forceHigh confidence
US 8,696,633Operating an Infusion Pump System
In force
 · High confidence
In forceHigh confidence
US 7,789,859Operating an Infusion Pump System
In force
 · Medium confidence
In forceMedium confidence
US 8,152,765Infusion Pump System with Contamination-Resistant Features
In force
 · High confidence
In forceHigh confidence
10 of 431 patents shown.
Pro members see all 431.
Pro members: see all 431 patents
Also on record, not counted in the 431: 4 patents in force now held by others · 56 patents ended · 212 applications pending · 54 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited